Podcast: Patient engagement throughout the product life cycle

Take a listen to this thought-provoking podcast as our CEO, Cheryl Lubbert shares her insights with pharmaphorum on best practices for engaging patients from pre-clinical through commercialization stages and beyond. Listen here https://lnkd.in/g7xyVECd In the podcast, Reverba CEO Cheryl Lubbert joins host Jonah Comstock to walk through the steps of the product life cycle and…

Take a listen to this thought-provoking podcast as our CEO, Cheryl Lubbert shares her insights with pharmaphorum on best practices for engaging patients from pre-clinical through commercialization stages and beyond. Listen here https://lnkd.in/g7xyVECd

In the podcast, Reverba CEO Cheryl Lubbert joins host Jonah Comstock to walk through the steps of the product life cycle and explore the role of the patient at each of those pre-clinical, commercialization and beyond stages. Cheryl also discusses the relationship between patient engagement, patient activation, patient centricity, and patient co-creation. She provides a wealth of examples from her experience as a long-time leader in the pharma industry to give context to the many ways to incorporate patients and their feedback into product discovery, clinical trials, product development, launch, and post-launch.

Finally, at the end of the podcast, Cheryl gets into a few other hot-button issues including diversity and representation, as well as AI and how it will affect patient engagement. The whole podcast underscores that patient engagement is not something that can be added to one step of a process and then checked off the list. Real patient engagement needs to be integrated into processes every step of the way. Tune in for more interesting and actionable tips about patient engagement in pharma.


The Latest

  • Medical Affairs ROI: Turning Scientific Engagement Into Measurable Impact
    Medical Affairs ROI: Turning Scientific Engagement Into Measurable Impact

    Interactions led by Medical Affairs, including scientific exchange with HCPs and engagement with patients and advocacy groups, can influence clinical decisions and patient behavior, but their impact is not always…

  • Cheryl Lubbert, CEO of Reverba Global, Named 2026 HBA Luminary Award Honoree
    Cheryl Lubbert, CEO of Reverba Global, Named 2026 HBA Luminary Award Honoree

    Cheryl Lubbert, CEO of Reverba Global, has been named a 2026 HBA Luminary Award honoree by the Healthcare Businesswomen’s Association. The recognition reflects her leadership in advancing scientific engagement and…

  • Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes
    Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes

    At Patients as Partners 2026, CEO Cheryl Lubbert shared how sustaining patient engagement through organizational change requires intentional design, with systems built to hold as teams, priorities, and programs shift.